| Basics |
Avadel Pharmaceuticals plc
Avadel Pharmaceuticals PLC is a specialty pharmaceutical company developing and commercializing pharmaceutical products. The company's products include Bloxiverz, Vazculep, Akovaz, Karbinal ER, AcipHex Sprinkle, Cefaclor and Flexichamber.
|
| IPO Date: |
July 1, 1996 |
| Sector: |
Healthcare |
| Industry: |
Pharma |
| Market Cap: |
$1.01B |
| Activated in VL: |
True |
| Average Daily Range |
| Avg Daily Range: |
$0.23 | 3.06%
|
| Avg Daily Range (30 D): |
$0.21 | 2.14%
|
| Avg Daily Range (90 D): |
$0.20 | 2.28%
|
| Institutional Daily Volume |
| Avg Daily Volume: |
.65M |
| Avg Daily Volume (30 D): |
1.12M |
| Avg Daily Volume (90 D): |
.97M |
| Trade Size |
| Avg Trade Size (Sh.): |
133 |
| Avg Trade Size (Sh.) (30 D): |
77 |
| Avg Trade Size (Sh.) (90 D): |
76 |
| Institutional Trades |
| Total Inst.Trades: |
1,087 |
| Avg Inst. Trade: |
$1.61M |
| Avg Inst. Trade (30 D): |
$2.4M |
| Avg Inst. Trade (90 D): |
$1.8M |
| Avg Inst. Trade Volume: |
.15M |
| Avg Inst. Trades (Per Day): |
1 |
| Market Closing Trades |
| Avg Closing Trade: |
$1.82M |
| Avg Closing Trade (30 D): |
$1.6M |
| Avg Closing Trade (90 D): |
$1.35M |
| Avg Closing Volume: |
155K |
|
|
| Financials |
| |
TTM |
Q3 2024 |
Q2 2024 |
|
Basic EPS
|
$-.05
|
$-.03
|
$-.14
|
|
Diluted EPS
|
$-.05
|
$-.03
|
$-.14
|
|
Revenue
|
$ 52.51M
|
$ 50.03M
|
$ 41.5M
|
|
Gross Profit
|
$ 46.93M
|
$ 43.87M
|
$ 38.72M
|
|
Net Income / Loss
|
$ -4.92M
|
$ -2.63M
|
$ -13.82M
|
|
Operating Income / Loss
|
$ -3M
|
$ -.33M
|
$ -12.74M
|
|
Cost of Revenue
|
$ 5.58M
|
$ 6.16M
|
$ 2.79M
|
|
Net Cash Flow
|
$ 5M
|
$ -.27M
|
$ -6.95M
|
|
PE Ratio
|
|
|
|
|
|
|
